-+ 0.00%
-+ 0.00%
-+ 0.00%

Bide Pharmaceutical (688073.SH) announced its results for the first three quarters, with net profit of 164 million yuan to mother, an increase of 36.92% over the previous year

Zhitongcaijing·10/29/2026 11:49:11
Listen to the news

According to Zhitong Finance App News, Bide Pharmaceutical (688073.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 1,051 million yuan, up 7.37% year on year; net profit to mother was 164 million yuan, up 36.92% year on year; after deducting non-net profit of 143 million yuan, up 39.11% year on year; basic earnings per share were 1.90 yuan.